Evidence map›Paper›PMID 30940290›Full record

ArticleOncology research2019

Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway.

Jie Xu, Zhongzhou Su, Qiuping Ding, Liang Shen, Xiaohu Nie, Xuyan Pan, Ai Yan, Renfu Yan, Yue Zhou, Liqin Li and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Knockout ofInternational journal of ophthalmology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jie XuDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Zhongzhou SuDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Qiuping DingDepartment of Surgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Liang ShenDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Xiaohu NieDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Xuyan PanDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Ai YanDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Renfu YanDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Yue ZhouDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Liqin LiHuzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Bin LuDepartment of Neurosurgery, Huzhou Central Hospital, Huzhou, Zhejiang, P.R. China.
Huzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human glioblastoma multiforme (GBM) accounts for the majority of human brain gliomas. Several TMEM proteins, such as TMEM 45A, TMEM 97, and TMEM 140, are implicated in human brain gliomas. However, the roles of TMEM168 in human GBM remain poorly understood. Herein we found that mRNA levels of TMEM168 were overexpressed in GBM patients (

Indexed as

beta CateninBrain NeoplasmsCarcinogenesisCase-Control StudiesCell Line, TumorCell ProliferationFemaleGene Knockdown TechniquesGenes, Tumor SuppressorGlioblastomaHumansMaleMembrane ProteinsMiddle AgedRNA, MessengerSuppression, Geneticbeta CateninCTNNB1 protein, humanMembrane ProteinsRNA, MessengerTMEM168 protein, human

Identifiers

PMID30940290
PMCPMC7848296
OpenAlexW2931475968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.